Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Willem Alffenaar

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2020
Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment ResponseXubin Zheng, Ziwei Bao, Lina Davies Forsman, et al.
Clinical Pharmacology and Therapeutics|February 10, 2021
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for AntibioticsSebastian G Wicha, Anne-Grete Märtson, Elisabet I Nielsen, et al.
International Journal of Antimicrobial Agents|September 22, 2021
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelinesCindy Lau, Deborah Marriott, Hayley B Schultz, et al.
Frontiers in Pharmacology|January 26, 2023
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosisHaoyue Zhang, Yuying He, Lina Davies Forsman, et al.
The European Respiratory Journal|November 5, 2021
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in ChinaXubin Zheng, Lina Davies Forsman, Ziwei Bao, et al.
Frontiers in Pharmacology|April 13, 2023
Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patientsGe Shao, Ziwei Bao, Lina Davies Forsman, et al.
International Journal of Antimicrobial Agents|May 15, 2017
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational studyHeleen Aardema, Prashant Nannan Panday, Mireille Wessels, et al.
BMJ Open Respiratory Research|August 16, 2020
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre studySamiksha Ghimire, Samriddhi Karki, Bhagwan Maharjan, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2021
Saliva-based linezolid monitoring on a mobile UV spectrophotometerHannah Yejin Kim, Evelien Ruiter, Erwin M Jongedijk, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosisJohanna Kuhlin, Lina Davies Forsman, Aisha Osman, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2020
Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment ResponseXubin Zheng, Ziwei Bao, Lina Davies Forsman, et al.
Clinical Pharmacology and Therapeutics|February 10, 2021
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for AntibioticsSebastian G Wicha, Anne-Grete Märtson, Elisabet I Nielsen, et al.
International Journal of Antimicrobial Agents|September 22, 2021
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelinesCindy Lau, Deborah Marriott, Hayley B Schultz, et al.
Frontiers in Pharmacology|January 26, 2023
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosisHaoyue Zhang, Yuying He, Lina Davies Forsman, et al.
The European Respiratory Journal|November 5, 2021
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in ChinaXubin Zheng, Lina Davies Forsman, Ziwei Bao, et al.
Frontiers in Pharmacology|April 13, 2023
Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patientsGe Shao, Ziwei Bao, Lina Davies Forsman, et al.
International Journal of Antimicrobial Agents|May 15, 2017
Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: a prospective observational studyHeleen Aardema, Prashant Nannan Panday, Mireille Wessels, et al.
BMJ Open Respiratory Research|August 16, 2020
Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre studySamiksha Ghimire, Samriddhi Karki, Bhagwan Maharjan, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2021
Saliva-based linezolid monitoring on a mobile UV spectrophotometerHannah Yejin Kim, Evelien Ruiter, Erwin M Jongedijk, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosisJohanna Kuhlin, Lina Davies Forsman, Aisha Osman, et al.
Pageof 10